Student work: 'Princeton Against Meningitis'

By Student Health Advisory Board on Dec. 3, 2013, 12:25 p.m.
Play video:

The Student Health Advisory Board speaks with some of the Princeton students who have had meningitis and with Dr. Janet Neglia of University Health Services. Eligible University community members who did not receive the Meningitis B vaccine in December 2013 may receive the first dose of the vaccine on Jan. 15-16 in the Frist Campus Center. A second dose of the vaccine will be available Feb. 17-20 in the Frist Campus Center. Two doses are needed for maximum protection. For more information visit the University's meningitis information website.

Related Stories

Student work: 'Princeton Against Meningitis Part Two' .

Princeton students talk about the importance of the second meningitis B vaccine. A second dose of the vaccine will be available for eligible groups from noon to 8 p.m. Feb. 17-20 in the Frist Campus Center. Two doses are needed for maximum protection. For more information visit the University's meningitis information website.

UPDATE Dec. 12: More than 5,200 receive meningitis B vaccines .

Princeton University has provided the first dose of the meningitis B vaccine to 5,268 individuals, which represent 91 percent of the approximately 5,800 University community members who were eligible to receive the vaccine. Vaccinations were given during clinics in Frist Campus Center from Monday through Thursday, Dec. 9-12.

University provides meningitis B vaccine during campus clinics .

Princeton University began providing the first dose of the meningitis B vaccine to recommended campus groups on Monday, Dec. 9, with 1,959 individuals vaccinated by the end of the first day. At the conclusion of the clinics on Thursday night, the total number vaccinated was 5,268. The vaccine clinics are being held from noon to 8 p.m. Monday through Thursday, Dec. 9-12, in the Frist Campus Center multipurpose room.

University will offer Meningitis B vaccines to recommended groups .

The Centers for Disease Control and Prevention (CDC) has now officially recommended that all Princeton University undergraduate students, and also graduate students living in undergraduate dormitories, the Graduate College and annexes, and other members of the University community with certain medical conditions, receive a vaccine that helps protect against meningococcal disease caused by serogroup B bacteria. The vaccine will be provided only to these groups, and it will not be administered anywhere else.

Meningitis B vaccine being considered at Princeton .

At the request of the New Jersey Department of Health (NJDOH), the Centers for Disease Control and Prevention (CDC) reviewed the seven cases of meningococcal disease contracted by Princeton University students and a student visitor since March 2013, all of which were caused by meningococcal bacteria known as serogroup B, including the latest case reported on Nov. 10.

University provides second dose of meningitis B vaccine .

Princeton University began providing a second dose of the meningitis B vaccine to recommended campus groups on Monday, Feb. 17, with 3,215 individuals vaccinated by the end of the third day. Another 305 individuals received the second dose last month. The vaccine clinics are being held from noon to 8 p.m. Monday through Thursday, Feb. 17-20, in the Frist Campus Center multipurpose room. More information about the clinics is available on the University's meningitis website.

University researcher to conduct meningitis vaccine study .

A Princeton University researcher is recruiting students to participate in a study intended to learn more about the impact of the meningitis B vaccine that has been offered to members of the University community.